Silver nanocubes-based plasmon-enhanced fluorescence for amplified detection and in situ tracking of amyloid-β aggregate
摘要
Alzheimer’s disease (AD) is a prevalent neurodegenerative disorder characterized by the pathological aggregation of amyloid-β (Aβ) protein. In this study, a plasmon-enhanced fluorescence (PEF) sensor based on Ag nanocubes (Agcubes) was developed for in situ imaging and tracking of Aβ1−42 (Aβ42) aggregation states. By precisely tuning the thickness of the silicon shell of the PEF sensor, the distance between rose bengals (RB) and Agcubes was optimized, leading to a remarkable 7.4-fold enhancement in fluorescence signal compared to RB. This sensor exhibited a significant “turn-on” response towards Aβ42 aggregation, with an approximate 4.5-fold increase in fluorescence. Notably, the sensor could be successfully applied to detect and locate the process of Aβ42 aggregation in living human neuroblastoma (SH-SY5Y) cells. Additionally, its staining sites were nearly identical to those of the commercial dye thioflavin T (ThT). This method enabled real-time in situ monitoring of intracellular Aβ42 aggregation state, demonstrating great potential as a reliable diagnostic tool for AD.
Graphical abstract